Vixiar Medical Inc., a privately held company in Baltimore focused on noninvasive devices and systems for monitoring cardiopulmonary diseases, closed its most recent financing of $1.5 million from new and existing investors. Proceeds will be used to complete an ongoing clinical trial and to prepare regulatory submissions.
To read more on related topics, click on one of the words below.